Visualitza per autor "CROS COSTA, SARA"
Ara mostrant els elements 1-3 d 3
-
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
Jiménez, Natalia; Garcia de Herreros, Marta; Marín-Aguilera, Mercedes; Aversa, Caterina; Ferrer-Mileo, Laura; CROS COSTA, SARA; Reig Torras, Oscar (Elsevier, 2024-03-01) -
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting
Romeo, Margarita; Gaba, Lydia; Teruel, Iris; Taus, Alvaro; Fina, Claudia; Gil Martín, Marta; Cros Costa, Sara (MDPI, 2022-09-11) -
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel
Marín-Aguilera, Mercedes; Font, Albert; Reig Torras, Oscar; Jiménez, Natalia; Cros Costa, Sara; Aversa, Caterina; Ferrer-Mileo, Laura (MDPI, 2022-09-29)